Dalpiciclib with endocrine therapy treats HR-positive advanced breast cancer in visceral crisis
In advanced breast cancer, few clinical situations are as ominous as visceral crisis — the rapid, life-threatening spread of disease ...
Tag: Phase 2 clinical trial
Phase 2 Trial Assesses c-Abl Inhibitor for Early Parkinson’s
In a landmark clinical advancement poised to reshape the therapeutic landscape of neurodegenerative disorders, researchers have unveiled compelling data on ...
Biomarkers Predict Response to Palbociclib-Anastrozole Therapy
In an intense and promising leap forward in the fight against breast cancer, researchers have unveiled groundbreaking findings on the ...
Faeth Therapeutics and The Gog Foundation, Inc. Unveil Phase 2 Combination Trial of Sapanisertib and Serabelisib for Endometrial Cancer Patients
In a groundbreaking development in cancer treatment, Faeth Therapeutics, a clinical-stage biotechnology firm, in partnership with The GOG Foundation, Inc, ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!